Skip to main content

Table 1 Demographics and Clinical Characteristics

From: A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence

 

Control Group (N = 16)

Treatment Group (N = 16)

P-value

Age (years, mean ± SD

57 ± 12

53 ± 10

0.28

Gravida (median, range)

2 (1–4)

2 (1–3)

NS

Parity (median, range)

2 (1–3)

2 (1–5)

NS

BMI (kg/m2, mean ± SD)

26.6 ± 5.3

28.6 ± 5.9

0.32

History of vaginal delivery (n, %)

14 (87)

16 (100)

NS

Postmenopausal (n, %)

9 (56)

8 (50)

NS

POP-Q stage (median, range)

2 (1–2)

2 (1–2)

NS

MESA SUI index (%, mean ± SD)

57 ± 20

49 ± 19

0.25

MESA UUI index (%, mean ± SD)

13 ± 14

17 ± 13

0.46

MESA SUI score (mean ± SD)

15.3 ± 5.5

13.2 ± 5.0

0.25

Severity of SUI

   

Mild (n, %)

3 (19)

5 (31)

 

Moderate (n, %)

8 (50)

8 (50)

 

Severe (n, %)

5 (31)

3 (19)

 
  1. NS: not significant, POP-Q: pelvic organ prolapse quantification, SUI: stress urinary incontinence, UUI: urge urinary incontinence, MESA: Medical, epidemiologic, and social aspects of aging urinary incontinence questionnaire, Stress urinary incontinence severity category: scores of 1 to 9 is assigned as mild, 10 to 18 as moderate, and 19 to 27 as severe